New and updated reports from the Congressional Research Service which have not been made publicly accessible include the following.
Alternative Fuel and Advanced Vehicle Technology Incentives: A Summary of Federal Programs, June 12, 2012
SBA New Markets Venture Capital Program, June 12, 2012
Health Insurance Premium Credits in the Patient Protection and Affordable Care Act (ACA), June 13, 2012
The U.S. Postal Service: Common Questions About Post Office Closures, June 13, 2012
Multiyear Procurement (MYP) and Block Buy Contracting in Defense Acquisition: Background and Issues for Congress, June 13, 2012
Iraq: Politics, Governance, and Human Rights, June 13, 2012
The Jackson-Vanik Amendment and Candidate Countries for WTO Accession: Issues for Congress, June 13, 2012
Russia’s Accession to the WTO and Its Implications for the United States, June 13, 2012
Permanent Normal Trade Relations (PNTR) Status for Russia and U.S.-Russian Economic Ties, June 13, 2012
Navy Littoral Combat Ship (LCS) Program: Background, Issues and Options for Congress, June 13, 2012
Navy DDG-51 and DDG-1000 Destroyer Programs: Background and Issues for Congress, June 12, 2012
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.